BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

700 related articles for article (PubMed ID: 16891297)

  • 21. Ovarian reserve.
    Coccia ME; Rizzello F
    Ann N Y Acad Sci; 2008 Apr; 1127():27-30. PubMed ID: 18443326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation.
    Jayaprakasan K; Campbell B; Hopkisson J; Johnson I; Raine-Fenning N
    Fertil Steril; 2010 Feb; 93(3):855-64. PubMed ID: 19046583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exogenous follicle stimulating hormone ovarian reserve test (EFORT): a simple and reliable screening test for detecting 'poor responders' in in-vitro fertilization.
    Fanchin R; de Ziegler D; Olivennes F; Taieb J; Dzik A; Frydman R
    Hum Reprod; 1994 Sep; 9(9):1607-11. PubMed ID: 7836508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The predictive value of ovarian reserve tests for spontaneous pregnancy in subfertile ovulatory women.
    Haadsma ML; Groen H; Fidler V; Bukman A; Roeloffzen EM; Groenewoud ER; Broekmans FJ; Heineman MJ; Hoek A
    Hum Reprod; 2008 Aug; 23(8):1800-7. PubMed ID: 18567901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
    Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
    Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Value of serum inhibin B measurement in predicting ovarian response in controlled ovarian hyperstimulation for in vitro fertilization cycle].
    Chen Y; Yu Q; Zhang YW; He FF; Sun ZY
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):368-71. PubMed ID: 16831355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
    Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clomiphene citrate challenge test versus the exogenous follicle-stimulating hormone ovarian reserve test as a single test for identification of low responders and hyperresponders to in vitro fertilization.
    Kwee J; Schats R; McDonnell J; Schoemaker J; Lambalk CB
    Fertil Steril; 2006 Jun; 85(6):1714-22. PubMed ID: 16650416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relevance of anti-Mullerian hormone measurement in a routine IVF program.
    Gnoth C; Schuring AN; Friol K; Tigges J; Mallmann P; Godehardt E
    Hum Reprod; 2008 Jun; 23(6):1359-65. PubMed ID: 18387961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
    Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
    Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antral follicle count and FSH concentration after clomiphene citrate challenge test in the prediction of ovarian response during IVF treatment.
    Ng EH; Chan CC; Tang OS; Ho PC
    Hum Reprod; 2005 Jun; 20(6):1647-54. PubMed ID: 15734749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis.
    Broer SL; Dólleman M; van Disseldorp J; Broeze KA; Opmeer BC; Bossuyt PM; Eijkemans MJ; Mol BW; Broekmans FJ;
    Fertil Steril; 2013 Aug; 100(2):420-9.e7. PubMed ID: 23721718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.
    Majumder K; Gelbaya TA; Laing I; Nardo LG
    Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The predictive value of ovarian reserve tests for miscarriage in a population of subfertile ovulatory women.
    Haadsma ML; Groen H; Fidler V; Seinen LH; Broekmans FJ; Heineman MJ; Hoek A
    Hum Reprod; 2009 Mar; 24(3):546-52. PubMed ID: 19059944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Müllerian hormone.
    Hamdine O; Eijkemans MJ; Lentjes EW; Torrance HL; Macklon NS; Fauser BC; Broekmans FJ
    Hum Reprod; 2015 Jan; 30(1):170-8. PubMed ID: 25355590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective analysis of ovarian reserve markers as determinant in response to controlled ovarian stimulation in women undergoing IVF cycles in low resource setting in India.
    Singh N; Bahadur A; Malhotra N; Kalaivani M; Mittal S
    Arch Gynecol Obstet; 2013 Sep; 288(3):697-703. PubMed ID: 23529683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intercycle variability of ovarian reserve tests: results of a prospective randomized study.
    Kwee J; Schats R; McDonnell J; Lambalk CB; Schoemaker J
    Hum Reprod; 2004 Mar; 19(3):590-5. PubMed ID: 14998957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive value of antral follicle count and serum anti-Müllerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment?
    Lee Y; Kim TH; Park JK; Eum JH; Lee HJ; Kim J; Lyu SW; Kim YS; Lee WS; Yoon TK
    Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():151-155. PubMed ID: 29306180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive value of antral follicle count and anti-Müllerian hormone for follicle and oocyte developmental competence during the early prepubertal period in a sheep model.
    Torres-Rovira L; Gonzalez-Bulnes A; Succu S; Spezzigu A; Manca ME; Leoni GG; Sanna M; Pirino S; Gallus M; Naitana S; Berlinguer F
    Reprod Fertil Dev; 2014 Oct; 26(8):1094-106. PubMed ID: 24008140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of ovarian reserve markers in prediction of clinical pregnancy.
    Zebitay AG; Cetin O; Verit FF; Keskin S; Sakar MN; Karahuseyinoglu S; Ilhan G; Sahmay S
    J Obstet Gynaecol; 2017 May; 37(4):492-497. PubMed ID: 28421902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.